Hanmi Science Co.,Ltd Logo

Hanmi Science Co.,Ltd

A holding company managing R&D-focused pharmaceutical, API, and medical device firms.

008930 | KO

Overview

Corporate Details

ISIN(s):
KR7008930000
LEI:
Country:
South Korea
Address:
경기도 화성시 팔탄면 무하로 214 한미약품(주) 팔탄공단, 화성시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Hanmi Science Co., Ltd. is a holding company that serves as the parent for a group of enterprises in the pharmaceutical and healthcare sectors. The company's operations are conducted through its key subsidiaries, including Hanmi Pharmaceutical, a leading R&D-centric biopharmaceutical firm; Hanmi Fine Chemical, a manufacturer of Active Pharmaceutical Ingredients (APIs); and Hanmi Healthcare, which develops and distributes medical devices. The group collectively engages in the research, development, manufacturing, and sale of a broad portfolio of products, including prescription drugs for various therapeutic areas and innovative medical devices for clinical settings. Hanmi Science provides strategic oversight and management for its subsidiaries, focusing on innovation and fair competition in the pharmaceutical market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Regulatory News Service
[기재정정]투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 14.0 KB
2025-09-03 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 412.8 KB
2025-09-03 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 410.3 KB
2025-09-03 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 75.2 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 204.6 KB
2025-08-29 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 200.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 3.1 MB
2025-08-11 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-30 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 77.4 KB
2025-07-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-25 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 15.4 KB
2025-07-25 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 288.7 KB
2025-07-18 00:00
Report Publication Announcement
결산실적공시예고(안내공시)
Korean 4.3 KB
2025-06-30 00:00
Major Shareholding Notification
조회공시요구(풍문또는보도)에대한답변(미확정)
Korean 4.9 KB
2025-06-30 00:00
Major Shareholding Notification
최대주주등소유주식변동신고서
Korean 73.5 KB

Automate Your Workflow. Get a real-time feed of all Hanmi Science Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hanmi Science Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hanmi Science Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CHAMPIONS ONCOLOGY, INC. Logo
Oncology CRO accelerating drug development with PDX models and multi-omic data analytics.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
Global CRO for pharma & biotech, offering research models, safety testing & manufacturing solutions.
United States of America
CRL
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus
CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea
030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan
4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan
190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden
CHOSA
Cidara Therapeutics, Inc. Logo
Developing drug-Fc conjugates as targeted immunotherapies for cancer and serious infections.
United States of America
CDTX
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan
4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan
7379

Talk to a Data Expert

Have a question? We'll get back to you promptly.